News

Clever Culture’s APAS is now on trial with Novo Nordisk, and if it delivers, this one machine could unlock a global pharma ...
The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...
This next iteration of AI is poised to transform biomanufacturing by overcoming challenges that, today, are insurmountable.
Steatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early detection of advanced liver disease through screening presents an opportunity ...
NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs ...
Studiet viser, at 89 procent af personer, der rammes af skizofreni, ikke har noget fortilfælde blandt første- og ...
The National Unit for Special Crime (National enhed for Særlig Kriminalitet, NSK) has arrested and charged a former employee of Copenhagen Municipality for using the CPR system to help plan a ...
The iShares S&P 500 ETF (ASX: IVV) has been one of the best performers over the last ten years, producing an average annual ...